{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T08:17:00Z","timestamp":1783153020074,"version":"3.54.6"},"reference-count":59,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005205","name":"Johnson & Johnson Innovative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Forschung, Technologie und Raumfahrt","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022690","name":"JDRF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022690","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016118","name":"KfH-Stiftung Pr\u00e4ventivmedizin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016118","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["115974"],"award-info":[{"award-number":["115974"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.xkme.2026.101409","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:37:48Z","timestamp":1778765868000},"page":"101409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Systematic Evaluation of Plasma and Urine Metabolites to Predict the Risk of Adverse Kidney-related Outcomes in Chronic Kidney Disease: The GCKD Study\u2217"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2692-1192","authenticated-orcid":false,"given":"Elena","family":"Butz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Steinbrenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulla T.","family":"Schultheiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Behning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Hansmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Gronwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Oefner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Schaeffner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Uwe","family":"Eckardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"K\u00f6ttgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy","family":"Sekula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9887","key":"10.1016\/j.xkme.2026.101409_bib1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0140-6736(13)60439-0","article-title":"Evolving importance of kidney disease: from subspecialty to global health burden","volume":"382","author":"Eckardt","year":"2013","journal-title":"Lancet Lond Engl"},{"issue":"9888","key":"10.1016\/j.xkme.2026.101409_bib2","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","article-title":"Chronic kidney disease: global dimension and perspectives","volume":"382","author":"Jha","year":"2013","journal-title":"Lancet Lond Engl"},{"issue":"2","key":"10.1016\/j.xkme.2026.101409_bib3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.kisu.2017.07.005","article-title":"Strategies to improve monitoring disease progression, assessing cardiovascular risk, and defining prognostic biomarkers in chronic kidney disease","volume":"7","author":"Pena","year":"2017","journal-title":"Kidney Int Suppl"},{"issue":"7","key":"10.1016\/j.xkme.2026.101409_bib4","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2217\/bmm-2019-0008","article-title":"An update of urine and blood metabolomics in chronic kidney disease","volume":"13","author":"Kalantari","year":"2019","journal-title":"Biomark Med"},{"issue":"3","key":"10.1016\/j.xkme.2026.101409_bib5","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.kint.2019.11.010","article-title":"Epidemiology research to foster improvement in chronic kidney disease care","volume":"97","author":"Luo","year":"2020","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.xkme.2026.101409_bib6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/ndt\/gfae209","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease in children and adults: a commentary from the European Renal Best Practice (ERBP)","volume":"40","author":"Iatridi","year":"2025","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.xkme.2026.101409_bib7","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1681\/ASN.2020071077","article-title":"Kidney failure prediction models: a comprehensive external validation study in patients with advanced CKD","volume":"32","author":"Ramspek","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"15","key":"10.1016\/j.xkme.2026.101409_bib8","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/jama.2011.451","article-title":"A predictive model for progression of chronic kidney disease to kidney failure","volume":"305","author":"Tangri","year":"2011","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.xkme.2026.101409_bib9","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1001\/jama.2015.18202","article-title":"Multinational assessment of accuracy of equations for predicting risk of kidney failure: a meta-analysis","volume":"315","author":"Tangri","year":"2016","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.xkme.2026.101409_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002955","article-title":"The kidney failure risk equation for prediction of end stage renal disease in UK primary care: An external validation and clinical impact projection cohort study","volume":"16","author":"Major","year":"2019","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.xkme.2026.101409_bib11","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12882-021-02402-1","article-title":"A validation study of the kidney failure risk equation in advanced chronic kidney disease according to disease aetiology with evaluation of discrimination, calibration and clinical utility","volume":"22","author":"Ali","year":"2021","journal-title":"BMC Nephrol"},{"issue":"3","key":"10.1016\/j.xkme.2026.101409_bib12","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1681\/ASN.0000000000000050","article-title":"The kidney failure risk equation: evaluation of novel input variables including eGFR estimated using the CKD-EPI 2021 equation in 59 Cohorts","volume":"34","author":"Grams","year":"2023","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.xkme.2026.101409_bib13","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfaf258","article-title":"Kidney failure risk equation performance according to the etiology of chronic kidney disease in the CKD-CAREMEAU cohort","volume":"18","author":"Prouvot","year":"2025","journal-title":"Clin Kidney J"},{"issue":"1","key":"10.1016\/j.xkme.2026.101409_bib14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2215\/CJN.01290216","article-title":"Predicting 5-year risk of RRT in stage 3 or 4 CKD: development and external validation","volume":"12","author":"Schroeder","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.xkme.2026.101409_bib15","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.kint.2018.01.009","article-title":"Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate","volume":"93","author":"Grams","year":"2018","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.xkme.2026.101409_bib16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrneph.2017.30","article-title":"Metabolomics for clinical use and research in chronic kidney disease","volume":"13","author":"Hocher","year":"2017","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"10.1016\/j.xkme.2026.101409_bib17","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3390\/metabo11070460","article-title":"Chronic kidney disease cohort studies: a guide to metabolome analyses","volume":"11","author":"Schultheiss","year":"2021","journal-title":"Metabolites"},{"issue":"4","key":"10.1016\/j.xkme.2026.101409_bib18","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1093\/ndt\/gfr456","article-title":"The German chronic kidney disease (GCKD) study: design and methods","volume":"27","author":"Eckardt","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.xkme.2026.101409_bib19","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1053\/j.ajkd.2021.01.018","article-title":"Urine metabolite levels, adverse kidney outcomes, and mortality in CKD patients: a metabolome-wide association study","volume":"78","author":"Steinbrenner","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.xkme.2026.101409_bib20","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1093\/ndt\/gfac173","article-title":"Association of osteopontin with kidney function and kidney failure in chronic kidney disease patients: the GCKD study","volume":"38","author":"Steinbrenner","year":"2023","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.xkme.2026.101409_bib21","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1053\/j.ajkd.2024.03.028","article-title":"Associations of urine and plasma metabolites with kidney failure and death in a chronic kidney disease cohort","volume":"84","author":"Steinbrenner","year":"2024","journal-title":"Am J Kidney"},{"issue":"4","key":"10.1016\/j.xkme.2026.101409_bib22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/bimj.200810443","article-title":"The performance of risk prediction models","volume":"50","author":"Gerds","year":"2008","journal-title":"Biom J"},{"key":"10.1016\/j.xkme.2026.101409_bib23","first-page":"559","article-title":"Designing and implementing a biobanking IT framework for multiple research scenarios","volume":"180","author":"Prokosch","year":"2012","journal-title":"Stud Health Technol Inform"},{"issue":"3","key":"10.1016\/j.xkme.2026.101409_bib24","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/ndt\/gfu294","article-title":"Disease burden and risk profile in referred patients with moderate chronic kidney disease: composition of the German chronic kidney disease (GCKD) cohort","volume":"30","author":"Titze","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"10.1016\/j.xkme.2026.101409_bib25","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.xkme.2026.101409_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-66334-w","article-title":"Urine 6-bromotryptophan: associations with genetic variants and incident end-stage kidney disease","volume":"10","author":"Sekula","year":"2020","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.xkme.2026.101409_bib27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11306-007-0082-2","article-title":"Proposed minimum reporting standards for chemical analysis: chemical analysis working group (CAWG) metabolomics standards initiative (MSI)","volume":"3","author":"Sumner","year":"2007","journal-title":"Metabolomics"},{"issue":"12","key":"10.1016\/j.xkme.2026.101409_bib28","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1007\/s13361-016-1469-y","article-title":"Untargeted metabolomics strategies\u2014challenges and emerging directions","volume":"27","author":"Schrimpe-Rutledge","year":"2016","journal-title":"J Am Soc Mass Spectrom"},{"issue":"13","key":"10.1016\/j.xkme.2026.101409_bib29","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1021\/ac051632c","article-title":"Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics","volume":"78","author":"Dieterle","year":"2006","journal-title":"Anal Chem"},{"issue":"10","key":"10.1016\/j.xkme.2026.101409_bib30","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s11306-018-1420-2","article-title":"Characterization of missing values in untargeted MS-based metabolomics data and evaluation of missing data handling strategies","volume":"14","author":"Do","year":"2018","journal-title":"Metabolomics"},{"issue":"12","key":"10.1016\/j.xkme.2026.101409_bib31","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1093\/ndt\/gfae092","article-title":"Interactive exploration of adverse events and multimorbidity in CKD","volume":"39","author":"Steinbrenner","year":"2024","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.xkme.2026.101409_bib32","article-title":"Heterogeneity of eGFR slopes according to etiology, eGFR and UACR in a large cohort of CKD patients","volume":"11","author":"Behning","year":"2025","journal-title":"Kidney Int Rep"},{"issue":"4","key":"10.1016\/j.xkme.2026.101409_bib33","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v038.i04","article-title":"Empirical Transition matrix of multi-state models: the etm PACKAGE","volume":"38","author":"Allignol","year":"2011","journal-title":"J Stat Softw"},{"issue":"7","key":"10.1016\/j.xkme.2026.101409_bib34","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.2215\/CJN.10301016","article-title":"Statistical methods for cohort studies of CKD: survival analysis in the setting of competing risks","volume":"12","author":"Hsu","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"446","key":"10.1016\/j.xkme.2026.101409_bib35","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"24","key":"10.1016\/j.xkme.2026.101409_bib36","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1001\/jama.2024.4970","article-title":"Accounting for competing risks in clinical research","volume":"331","author":"Austin","year":"2024","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.xkme.2026.101409_bib37","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/bioinformatics\/btp088","article-title":"Boosting for high-dimensional time-to-event data with competing risks","volume":"25","author":"Binder","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xkme.2026.101409_bib38","series-title":"Medical Risk Prediction: With Ties to Machine Learning","author":"Gerds","year":"2021"},{"key":"10.1016\/j.xkme.2026.101409_bib39","series-title":"riskRegression: risk regression models and prediction scores for survival analysis with competing risks","author":"Gerds","year":"2011"},{"issue":"30","key":"10.1016\/j.xkme.2026.101409_bib40","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1002\/sim.5958","article-title":"Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks","volume":"32","author":"Blanche","year":"2013","journal-title":"Stat Med"},{"issue":"4","key":"10.1016\/j.xkme.2026.101409_bib41","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1111\/j.1541-0420.2007.00832.x","article-title":"Efron-type measures of prediction error for survival analysis","volume":"63","author":"Gerds","year":"2007","journal-title":"Biometrics"},{"issue":"2","key":"10.1016\/j.xkme.2026.101409_bib42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/sim.4348","article-title":"Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models","volume":"31","author":"Pencina","year":"2012","journal-title":"Stat Med"},{"issue":"14","key":"10.1016\/j.xkme.2026.101409_bib43","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1002\/sim.5647","article-title":"A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data","volume":"32","author":"Uno","year":"2013","journal-title":"Stat Med"},{"key":"10.1016\/j.xkme.2026.101409_bib44","series-title":"survIDINRI: IDI and NRI for comparing competing risk prediction models with censored survival data","first-page":"1.1","author":"Hajime Uno","year":"2012"},{"issue":"2","key":"10.1016\/j.xkme.2026.101409_bib45","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1053\/j.ajkd.2021.05.018","article-title":"A predictive model for progression of CKD to kidney failure based on routine laboratory tests","volume":"79","author":"Zacharias","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.xkme.2026.101409_bib46","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bjc.6602678","article-title":"Reporting recommendations for tumour MARKer prognostic studies (REMARK)","volume":"93","author":"McShane","year":"2005","journal-title":"Br J Cancer"},{"issue":"12","key":"10.1016\/j.xkme.2026.101409_bib47","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/ki.2008.416","article-title":"Testing for causality and prognosis: etiological and prognostic models","volume":"74","author":"Tripepi","year":"2008","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.xkme.2026.101409_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17107-5","article-title":"From discovery to translation: characterization of C-mannosyltryptophan and pseudouridine as markers of kidney function","volume":"7","author":"Sekula","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.xkme.2026.101409_bib49","doi-asserted-by":"crossref","first-page":"F30","DOI":"10.1152\/ajprenal.00252.2022","article-title":"Tubular dysfunction impairs renal excretion of pseudouridine in diabetic kidney disease","volume":"326","author":"Mathew","year":"2024","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"10.1016\/j.xkme.2026.101409_bib50","doi-asserted-by":"crossref","first-page":"342","DOI":"10.2215\/CJN.10010818","article-title":"Serum metabolomic alterations associated with proteinuria in CKD","volume":"14","author":"Luo","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2026.101409_bib51","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2215\/CJN.08600520","article-title":"NAT8 variants, N-acetylated amino acids, and progression of CKD","volume":"16","author":"Luo","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2026.101409_bib52","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.kint.2021.09.032","article-title":"Metabolome-wide association study of estimated glomerular filtration rates in Hispanics","volume":"101","author":"Lin","year":"2022","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.xkme.2026.101409_bib53","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3390\/metabo12050372","article-title":"Intrapersonal stability of plasma metabolomic profiles over 10 years among women","volume":"12","author":"Zeleznik","year":"2022","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.xkme.2026.101409_bib54","doi-asserted-by":"crossref","first-page":"9810","DOI":"10.1038\/s41598-018-27958-1","article-title":"Instability of personal human metabotype is linked to all-cause mortality","volume":"8","author":"Lacruz","year":"2018","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.xkme.2026.101409_bib55","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.bbrc.2014.02.021","article-title":"A metabolomics-based approach for predicting stages of chronic kidney disease","volume":"445","author":"Kobayashi","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"issue":"21","key":"10.1016\/j.xkme.2026.101409_bib56","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1001\/jama.2019.17379","article-title":"Development of risk prediction equations for incident chronic kidney disease","volume":"322","author":"Nelson","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.xkme.2026.101409_bib57","doi-asserted-by":"crossref","DOI":"10.2202\/1544-6115.1346","article-title":"Adapting prediction error estimates for biased complexity selection in high-dimensional bootstrap samples","volume":"7","author":"Binder","year":"2008","journal-title":"Stat Appl Genet Mol Biol"},{"issue":"1","key":"10.1016\/j.xkme.2026.101409_bib58","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1021\/acs.jproteome.7b00518","article-title":"Long-term stability of human plasma metabolites during storage at -80 \u00b0C","volume":"17","author":"Haid","year":"2018","journal-title":"J Proteome Res"},{"issue":"5","key":"10.1016\/j.xkme.2026.101409_bib59","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3390\/metabo9050099","article-title":"Effects of long-term storage at \u221280 \u00b0C on the human plasma metabolome","volume":"9","author":"Wagner-Golbs","year":"2019","journal-title":"Metabolites"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059526001718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059526001718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T07:31:26Z","timestamp":1783150286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059526001718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2590059526001718"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2026.101409","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic Evaluation of Plasma and Urine Metabolites to Predict the Risk of Adverse Kidney-related Outcomes in Chronic Kidney Disease: The GCKD Study\u2217","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2026.101409","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101409"}}